Author: Cillian Osterfield

The FDA uses warning letters as its primary tool to enforce compliance among manufacturers. These letters target violations in pharmaceuticals, food, tobacco, and medical devices - with serious consequences for non-compliance, including product seizures, fines, and criminal charges.

Taking antacids with antibiotics can cut their effectiveness by up to 90%. Learn how to time your doses to avoid treatment failure and protect your health.

Azoles like voriconazole and posaconazole can dangerously raise tacrolimus levels in transplant patients, leading to kidney damage. Learn how this common interaction works, which azoles are riskiest, and how to prevent acute kidney injury with proven protocols.

Biosimilars are highly similar versions of complex biologic drugs, approved by the FDA to work just like the original. They're not generics, but they're safe, effective, and often cheaper. Here's what patients need to know.

FDA warning letters are serious enforcement actions targeting manufacturing violations in pharmaceuticals. Learn the common violations, response requirements, costs, and how to avoid them before it's too late.

Monitoring for suicidal ideation in adolescents on psychiatric medication is not optional-it's essential. Learn when risk peaks, what signs to watch for, and how to create a safety plan that works.

Learn how to link your daily habits - like brushing teeth or drinking coffee - to taking your medications. This simple, low-cost method can cut missed doses by up to 50% and works for people of all ages.

IVIVC lets regulators approve generic drugs without human trials by linking lab dissolution data to real-world absorption. Learn how Level A correlation saves millions and why most submissions fail.

Generics are supposed to be simple and affordable-but many now require insurance approval before you can get them. Here’s why it’s happening, how it affects you, and what you can do.

Predicting when a drug becomes generic involves patent timelines, FDA approvals, litigation, and market strategy. Learn how generics enter the market, why delays happen, and what drives price drops after exclusivity ends.